Lead Product(s) : Estradiol Valerate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Hikma Launches Estradiol Valerate Injection, USP
Details : Estradiol Valerate Injection USP is indicated (i) in the treatment of vasomotor symptoms associated with menopause (ii) in the management of hormonal imbalances due to castration or primary ovarian failure (iii) in the treatment of androgen-dependent car...
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
February 06, 2021
Lead Product(s) : Estradiol Valerate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
